Stratus® Medical announces first patient enrolled in important double-blinded, randomized, comparative trial comparing the Nimbus® radiofrequency ablation device to conventional radiofrequency ablation for the treatment of Sacroiliac Joint pain
MAGNOLIA, Texas, March 9, 2023 /OrthoSpineNews/ — Stratus® Medical, an organization targeted on advancing radiofrequency (RF) ablation remedy for ache, and the College of Utah, Division of Bodily Medication and Rehabilitation, introduced as we speak the primary affected person enrolled within the COBRA examine, a double-blinded, randomized trial, evaluating the bipolar remedy with Nimbus® RF Multitined Expandable Electrode to traditional radiofrequency ablation for the remedy of sacroiliac joint (SIJ) ache.
Research to Measure Radiofrequency Ablation Outcomes for Sacroiliac Joint Ache with Nimbus
This IRB-approved examine would be the first degree I, double-blinded, randomized management trial to check Nimbus bipolar radiofrequency ablation to traditional radiofrequency ablation at three-month, six-month, 12 month, 18 month, and 24 month endpoints. The purpose of the examine is to quantify effectiveness and period of aid for the favored bipolar software within the sacroiliac joint. This examine contemplates the enrollment and randomization of 116 sufferers on the College of Utah, and is supported by an investigator-initiated analysis grant from Stratus Medical. For extra data go to: https://www.clinicaltrials.gov/ct2/present/NCT05409443
Precept investigator, Dr. Aaron Conger, Assistant Professor and Interventional Backbone and Musculoskeletal Medication Doctor on the College of Utah within the Division of Bodily Medication and Rehabilitation (PM&R), commented “This examine will likely be one of many largest and finest designed SIJ RFA trials carried out up to now. We count on the outcomes will considerably affect apply patterns concerning electrode selection for a lot of physicians who deal with SIJ ache and can additional bolster the prevailing proof for SIJ radiofrequency ablation. We thank Stratus Medical for his or her partnership in funding this necessary analysis.”
Dr. Zachary McCormick, Affiliate Professor and Division Chief of Backbone and Musculoskeletal Medication on the College of Utah within the Division of PM&R, stated “The remedy of continual, refractory sacroiliac joint ache stays a difficult drawback. We’re happy to have the ability to contribute to the scientific science by this pragmatic randomized trial.”
Bret Boudousquie, Stratus Medical CEO, supplied “We’re delighted to help this necessary investigator-initiated analysis evaluating our extremely differentiated and patented Nimbus RF know-how to traditional RF needles for the remedy of sacroiliac joint ache. Nimbus is quickly turning into the popular massive quantity lesion nerve ablation know-how to deal with ache attributable to reproducible and sustained ache aid, sooner process occasions and decrease process price. We count on this analysis will additional validate the numerous scientific benefits of Nimbus in comparison with typical RF needles.”
About Stratus Medical – Stratus Medical is a medical system firm targeted on enhancing scientific outcomes for continual ache sufferers by advancing RF know-how for the remedy of ache. The Nimbus® RF Multitined Expandable Electrode addresses the unmet want for an easy-to-use and cost-effective radiofrequency ablation system that gives a big quantity lesion for predictable and sturdy ache aid. Stratus Medical is headquartered in Magnolia, Texas.
Media Contact Cody Jorgensen Advertising Communications Stratus Medical 346-703-0642 email@example.com https://stratusmedical.com